New drug target to combat Alzheimer’’s disease identifiedFebruary 13th, 2009 - 12:40 pm ICT by ANI
Washington, Feb 13 (ANI): Scientists at the Flanders Institute for Biotechnology (VIB) claim that they have discovered a potential therapeutic target for Alzheimers disease.
The team led by Amantha Thathiah, in collaboration with researchers from the biotech company Galapagos, have identified a protein called GPR3, which plays a key role in plaque build-up in the brain.
While experimenting on mice, the researchers observed that blocking GPR3 led to a reduction of the plaques.
The brains of Alzheimer’’s patients typically show the presence of amyloid plaques, which are abnormal accumulations of a protein (ss-amyloid) between the neurons.
Current medicines for Alzheimer’’s patients sustain the memory functions for a short time, but they are unable to stop the brain cells from dying off.
They are able to limit the loss of memory during the early phases of the disease.
The GPR3 protein is an important target molecule for the eventual development of a new medicine against Alzheimer’’s disease. (ANI)
- Novel gene therapy shows promise against Alzheimer's - Mar 05, 2011
- Scientists eliminate plaque formation in Alzheimer's - Sep 06, 2012
- Revolutionary jab to halt Alzheimer's may be available within two years - Apr 23, 2011
- Second molecule in Alzheimer's toxic duo identified - Feb 04, 2011
- Sleep disorders are early signs of Alzheimer's - Sep 06, 2012
- Drug reverses Alzheimer's symptoms in mice: Study - Feb 10, 2012
- Asthma drug could help fight Alzheimer's disease - Mar 26, 2011
- Blood vessel dysfunction linked to heart disease also plays role in Alzheimer's - Dec 03, 2010
- Scientists reverse loss of smell in early Alzheimer's - Dec 01, 2011
- Tobacco-derived compound prevents memory loss in Alzheimer's - Apr 28, 2011
- Potent new vaccine found effective against Alzheimer's - Jun 08, 2012
- Insulin could play powerful role in fighting Alzheimer's - Apr 02, 2011
- Link between Down syndrome, Alzheimer's disease discovered - Jan 13, 2011
- Protein behind Alzheimer's patients loss of smell? - Sep 29, 2011
- How Alzheimer's plaques lead to loss of nitric oxide in brain - Jan 11, 2011
Tags: amyloid plaques, biotech company, biotechnology, brain cells, brains, drug target, eventual development, flanders, galapagos, key role, loss of memory, medicines, memory functions, mice, new medicine, plaque, protein, short time, target molecule, therapeutic target